Bioretec Updates Product Pipeline to Accelerate Commercialization Strategy

Bioretec received FDA 510(k) clearance to market its bioresorbable RemeOs trauma screw. Following this market authorization, Bioretec has resolved to update and refocus the company’s product portfolio to facilitate an accelerated commercialization strategy and provide a more synergistic offering to the market. Further, Bioretec has refined...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us